# Tevogen Inc. (TVGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tevogen Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TVGN/mda/fy2025/): filed 2026-03-31; accession 0001493152-26-014326 (https://www.sec.gov/Archives/edgar/data/1860871/000149315226014326/form10-k.htm); latest 10-K
- [FY 2024 MD&A](/company/TVGN/mda/fy2024/): filed 2025-04-02; accession 0001641172-25-002426 (https://www.sec.gov/Archives/edgar/data/1860871/000164117225002426/form10-k.htm)
- [FY 2023 MD&A](/company/TVGN/mda/fy2023/): filed 2024-04-29; accession 0001493152-24-016796 (https://www.sec.gov/Archives/edgar/data/1860871/000149315224016796/form10-k.htm)
- [FY 2022 MD&A](/company/TVGN/mda/fy2022/): filed 2023-04-17; accession 0001410578-23-000698 (https://www.sec.gov/Archives/edgar/data/1860871/000141057823000698/lgstu-20221231x10k.htm)
- [FY 2021 MD&A](/company/TVGN/mda/fy2021/): filed 2022-04-01; accession 0001410578-22-000810 (https://www.sec.gov/Archives/edgar/data/1860871/000141057822000810/lgstu-20211231x10k.htm)

Back to /company/TVGN/